交易 ClearPoint Neuro Inc - CLPT
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system, a neuro-navigation system designed for instruments or devices designed to treat various neurological diseases and conditions, as well as for performing biopsies. In addition, the company''s product pipeline includes ClearTrace system, a product candidate designed to perform minimally invasive surgical procedures in the heart. It has license and collaboration agreements with The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Microsystems, LLC, and University of California and San Francisco. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Irvine, California.最新股票文章

Uber Technologies 股價預測:裁減 3,300 個職位,拓展機械人計程車業務
Uber 正進行重組,裁減約 3,300 個職位,同時在機械人計程車市場競爭加劇之際,擴大自動駕駛汽車合作關係。本文整理第三方對 UBER 的股價目標及技術分析。過往表現並非未來業績的可靠指標。
14 小時前

微軟股價預測 | Azure 營收與財報分部調整
微軟是一家美國科技公司。2026 財年,Azure 營收達 1,019 億美元,公司亦宣布將於 2027 財年採用新的財報分部架構。了解第三方 MSFT 目標價及技術分析。過往表現並非未來業績的可靠指標。
14:37, 25 9月 2026

NVIDIA 股價預測 | 收購 Hugging Face
了解第三方對 NVIDIA 股價的預測,涵蓋技術分析、差價合約交易情緒、NVDA 股價歷史及 Capital.com 分析師觀點。
12:13, 25 9月 2026
